Jim Simons acquired 224k Veracyte shares worth $11.2M. That's 0.02% of their equity portfolio (920th largest holding). The first Veracyte trade was made in Q4 2015. Since then Jim Simons bought shares seventeen more times and sold shares on fourteen occasions. The stake costed the investor $8.44M, netting the investor a gain of 32% so far.